Compounded Semaglutide: Official Information and Directory Limits
This directory cannot determine whether a compounded medication is safe or appropriate for an individual. The FDA page listed below provides the agency’s information about unapproved GLP-1 drugs; discuss questions about your care with a qualified clinician.
Semaglutide clinic price records in our directory: median $255 per month across 257 eligible clinic price records at 96 clinics (interquartile range $179–$349). Most recent record date: 2026-10-10. Updated 2026-11-12.
Read the official FDA information
The FDA maintains information about concerns related to unapproved GLP-1 drugs. Review the current agency page directly rather than relying on this directory to summarize an individual medical decision.
What this directory does not determine
Clinic listings and price records do not establish medication approval status, pharmacy quality, legal compliance, clinical safety, or whether a treatment is right for you.
Frequently asked questions
Does this page determine whether compounded semaglutide is safe?
No. This directory does not assess medication safety or individual treatment suitability. Review the FDA source and speak with a qualified clinician.
Does a clinic price record show that a medication is approved or appropriate?
No. A price record is only a source-linked price disclosure and does not establish approval status, quality, safety, or suitability.
Where can I find the FDA information referenced here?
Use the FDA page linked under Sources for the agency’s information about unapproved GLP-1 drugs.
Related
Sources
Last updated 2026-11-12. Figures summarize eligible clinic price records; source types and links are shown, and the amounts are not quotes. Confirm current pricing with the clinic.